Molecular Analysis for Therapy Choice (MATCH)

This study seeks to determine whether matching certain drugs or drug combinations in adults whose tumors have specific gene abnormalities will effectively treat their cancer, regardless of their cancer type. Such discoveries could be eligible to move on to larger, more definitive trials.


This research study is led by Dr. John McCann.

Contact: Dawn DeMarinis, 413-794-4362

Participation details:

August 12, 2015
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate
D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
Any solid tumor, lymphoma, or myeloma that has returned or gotten worse after standard systemic therapy OR a type of cancer for which no standard treatment exists that has been shown to prolong overall survival
Interventional (Clinical Trial), Non-Randomized